GADD45GIP1 and hepatocellular carcinoma: To evaluate the role of CRIF1 in promoting HCC tumorigenicity in vivo, mice were subcutaneously injected with HCC cells with CRIF1 knockdown (CRIF1-KD) or normal control (NC) cells.